drugset / Trial / NCT03666494

Ketamine Co-induction for Patients With Major Depressive Disorder

NCT03666494 ↗

Phase 4 Unknown 50 enrolled University of Saskatchewan
RandomizedParallel-groupTriple-blindTreatment

Summary

Ketamine hydrochloride, an anesthetic medication, has been demonstrated to acutely and rapidly improve depressive symptoms but not yet been adequately studied for this effect when used as part of a general anesthetic for surgery. This proposed single-centre, double-blinded, randomized clinical trial of adult patients with depression presenting for gynecologic surgery would compare severity of depressive symptoms between patients receiving and not receiving ketamine as part of their general anesthetic.

Timeline

Start
2018-12
Primary completion
2019-12
Completion
2019-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 0.5 mg/kg —
Comparator Fentanyl Other / unclassified — —
Comparator Propofol Small molecule — —